| Author (Person) | Jack, Andrew |
|---|---|
| Series Title | Financial Times |
| Series Details | 15.10.10 |
| Publication Date | 15/10/2010 |
| Content Type | News |
|
The first European company to produce a drug from a genetically modified animal began distributing its treatment to patients in the autumn of 2010. Pharming, based in the Netherlands, became the world’s first pharmaceutical group to derive a medicine from transgenic rabbits, using the milk they produce as the basis for its drug to treat a rare genetic disease. The product, approved by the European Medicines Agency in June 2010, would require a final formal ratification from the European Commission, which was expected in November 2010. Under the brand name Rhucin, it will be submitted for US regulatory approval by the end of 2010. |
|
| Related Links |
|
| Subject Categories | Business and Industry, Health |
| Countries / Regions | Europe, Netherlands |
